Mucometra and Hydrometra

Mucometra and hydrometra are non-infectious, non-inflammatory uterine conditions characterized by the accumulation of sterile fluid within the uterine lumen. Mucometra refers to the accumulation of mucinous, often thick, tenacious fluid, while hydrometra involves a more watery, serous transudate. These conditions are distinct from pyometra, which involves purulent, infected fluid. They occur most commonly in intact female dogs and cats, typically during the luteal phase (diestrus) or after prolonged progesterone influence. The uterine distension can be mild to severe, leading to abdominal enlargement, and may be associated with endometrial hyperplasia, cystic endometrial hyperplasia (CEH), or congenital anomalies such as segmental aplasia. In some cases, mucometra and hydrometra are incidental findings during routine imaging or ovariohysterectomy, but they can also cause clinical signs such as vaginal discharge, lethargy, and infertility. The condition is often considered a precursor to pyometra if secondary bacterial infection occurs. The pathophysiology involves an imbalance between endometrial secretion and resorption, often driven by progesterone, leading to fluid accumulation. The condition is more common in middle-aged to older intact females, and certain breeds may be predisposed. Diagnosis is typically achieved through ultrasonography, which reveals anechoic or hypoechoic fluid-filled uterine horns, and confirmed by histopathology after surgical removal. Treatment options include medical management with prostaglandins and antiprogestins, but ovariohysterectomy remains the definitive and most commonly recommended treatment, especially in non-breeding animals.

The primary etiology of mucometra and hydrometra is hormonal, specifically prolonged or excessive progesterone influence on the endometrium. Progesterone stimulates endometrial glandular secretion and inhibits myometrial contractility, leading to fluid accumulation. This can occur during normal diestrus, but is more pronounced in cases of cystic endometrial hyperplasia (CEH), which is often associated with repeated estrous cycles, nulliparity, and increasing age. Exogenous progestin administration (e.g., megestrol acetate, medroxyprogesterone acetate) used for estrus suppression or treatment of dermatological conditions can also induce these changes. Congenital anomalies such as segmental aplasia of the uterine horn, imperforate hymen, or vaginal strictures can cause fluid accumulation due to outflow obstruction. In cats, mucometra and hydrometra are often associated with cystic endometrial hyperplasia, which can be induced by exogenous progestins or occur spontaneously. Other contributing factors include uterine torsion, neoplasia (e.g., leiomyoma, adenocarcinoma) causing obstruction, and ovarian cysts that produce progesterone. In rare cases, chronic endometritis can lead to mucinous metaplasia of the endometrium. The fluid is typically sterile, but secondary bacterial colonization can convert the condition to pyometra. The exact cellular mechanisms involve upregulation of progesterone receptors, increased expression of growth factors (e.g., EGF, IGF), and altered aquaporin channels, leading to net fluid secretion. Genetic predisposition may play a role in certain breeds, such as the Bernese Mountain Dog, Rottweiler, and Golden Retriever, which have a higher incidence of CEH and pyometra.

Mucometra and hydrometra are relatively uncommon compared to pyometra, but they share similar epidemiological features. They occur almost exclusively in intact female dogs and cats, with a higher incidence in middle-aged to older animals (typically >6 years). Nulliparous females are at increased risk, as are those with a history of irregular estrous cycles or those that have received progestin therapy. In dogs, breeds such as the Bernese Mountain Dog, Rottweiler, Golden Retriever, and Irish Setter have a higher prevalence of CEH and related uterine diseases. In cats, the condition is often associated with exogenous progestin use for estrus suppression, and Siamese and Persian breeds may be overrepresented. The incidence is difficult to estimate because many cases are subclinical and only detected incidentally. However, in a study of 1000 intact female dogs presented for ovariohysterectomy, approximately 5% had some degree of uterine fluid accumulation, with mucometra/hydrometra accounting for a small proportion. The condition is more common in dogs than cats, and in both species, it is more frequently diagnosed during the luteal phase (diestrus) or after prolonged progesterone exposure. There is no sex predilection beyond the female sex, and parity does not protect against the condition. The use of progestin-based contraceptives is a significant iatrogenic risk factor, particularly in cats. Overall, the condition is a significant reproductive health issue because it can lead to infertility, secondary pyometra, and, in severe cases, uterine rupture and peritonitis.

The pathophysiology of mucometra and hydrometra revolves around hormonal dysregulation, primarily involving progesterone. Progesterone, secreted by the corpora lutea during diestrus, promotes endometrial glandular development and secretion, while simultaneously reducing myometrial contractility. This creates an environment conducive to fluid accumulation. In normal cycles, the endometrium undergoes cyclical changes, but in susceptible individuals, repeated exposure to progesterone leads to cystic endometrial hyperplasia (CEH), characterized by dilated endometrial glands and stromal proliferation. These cystic glands secrete excessive fluid, which accumulates in the uterine lumen. The fluid is typically sterile, but its composition varies: in mucometra, it is rich in mucin, giving it a thick, tenacious consistency; in hydrometra, it is more serous and watery. The accumulation is exacerbated by reduced uterine clearance due to decreased myometrial activity and cervical closure. In cases of outflow obstruction (e.g., segmental aplasia, vaginal stricture), fluid accumulates due to physical blockage. The endometrial changes are mediated by progesterone receptors, which are upregulated by estrogen priming during proestrus and estrus. Prolonged progesterone exposure also downregulates apoptosis of endometrial cells, leading to hyperplasia. Inflammatory mediators, such as prostaglandins and cytokines, may be involved, but the fluid is typically non-inflammatory. If bacteria ascend from the vagina, they can colonize the fluid, leading to pyometra. The systemic effects are usually minimal unless secondary infection occurs, but severe uterine distension can cause abdominal discomfort, pressure on other organs, and, rarely, uterine rupture. The condition can also impair fertility by interfering with sperm transport and embryo implantation.

Several intrinsic and extrinsic factors predispose to mucometra and hydrometra. Intrinsic factors include age (middle-aged to older), breed (e.g., Bernese Mountain Dog, Rottweiler, Golden Retriever, Irish Setter in dogs; Siamese and Persian in cats), nulliparity, and a history of irregular estrous cycles or cystic ovarian follicles. Hormonal imbalances, such as persistent corpora lutea or ovarian cysts that produce progesterone, can also predispose. Congenital anomalies of the reproductive tract, including segmental aplasia, imperforate hymen, and vaginal strictures, are significant intrinsic factors that cause outflow obstruction. Extrinsic factors include exogenous progestin administration (e.g., megestrol acetate, medroxyprogesterone acetate) for estrus suppression or treatment of behavioral or dermatological conditions. These drugs mimic the effects of endogenous progesterone and can induce CEH and fluid accumulation. Poor breeding management, such as breeding during inappropriate times, may lead to repeated estrous cycles without conception, increasing the risk of CEH. Environmental stress, such as overcrowding or poor hygiene, may increase the risk of secondary bacterial infection, converting mucometra/hydrometra to pyometra. Additionally, iatrogenic factors, such as improper administration of hormonal therapies, can contribute. The presence of uterine neoplasia, such as leiomyoma or adenocarcinoma, can also obstruct the uterine lumen and lead to fluid accumulation. Overall, the interplay of hormonal, anatomical, and environmental factors determines the development of the condition.

Clinical signs of mucometra and hydrometra vary depending on the severity of fluid accumulation and the presence of secondary infection. In mild cases, animals may be asymptomatic, and the condition is often discovered incidentally during routine imaging or ovariohysterectomy. When signs are present, they may include a mucoid or watery vaginal discharge, which can be clear, white, or slightly yellowish. The discharge is typically odorless and non-purulent. Abdominal distension may be noticeable in severe cases, and palpation may reveal a tubular, fluid-filled uterus. Some animals may exhibit lethargy, depression, or mild anorexia, but systemic signs are usually absent unless secondary pyometra develops. In cases of outflow obstruction, such as segmental aplasia, the fluid may accumulate in a blind sac, causing a palpable mass. In cats, signs may be more subtle, and the condition is often detected during workup for infertility or routine health checks. In rare cases, uterine rupture can occur, leading to peritonitis, which presents with acute abdomen, vomiting, and shock. Behavioral changes, such as increased thirst or urination, are uncommon unless secondary infection occurs. Reproductive signs include failure to conceive, irregular estrous cycles, or abortion if the animal is pregnant. On vaginal examination, the cervix may be closed or slightly patent, and the vaginal mucosa may appear normal. Rectal examination may reveal uterine enlargement in large breeds. Overall, the clinical presentation is often mild and nonspecific, emphasizing the importance of diagnostic imaging.

Differential diagnoses for mucometra and hydrometra include: 1) Pyometra: The most important differential, characterized by purulent, often malodorous vaginal discharge, systemic signs (fever, lethargy, polyuria/polydipsia), and leukocytosis. Ultrasonographically, pyometra typically shows a more echogenic fluid with a thickened uterine wall, and the animal is usually more clinically ill. 2) Pregnancy: In early pregnancy, the uterus may contain fluid, but the presence of fetal heartbeats and embryonic vesicles on ultrasound confirms pregnancy. 3) Cystic endometrial hyperplasia (CEH): This is a precursor to mucometra/hydrometra and may coexist. CEH is characterized by multiple cystic endometrial glands, which can be seen on ultrasound as small anechoic areas within the uterine wall. 4) Uterine neoplasia: Tumors such as leiomyoma, leiomyosarcoma, or adenocarcinoma can cause uterine enlargement and fluid accumulation. Imaging may reveal a mass, and histopathology is definitive. 5) Vaginal or cervical stricture/imperforate hymen: These congenital anomalies can cause fluid accumulation in the uterus, but the fluid is often trapped behind the obstruction. 6) Mucometra associated with ovarian cysts: Ovarian cysts (e.g., follicular cysts, luteal cysts) can produce hormones that stimulate endometrial secretion, leading to fluid accumulation. 7) Endometritis: Chronic endometritis can cause a mucoid discharge, but it is usually associated with bacterial infection and may have a purulent component. 8) Uterine torsion: This is an acute condition with severe abdominal pain and shock, and the uterus is often distended with fluid or blood. 9) Fetal mummification or maceration: These can cause uterine enlargement and fluid accumulation, but there is a history of pregnancy loss. 10) Ascites or other abdominal fluid accumulation: This can mimic uterine distension on palpation, but imaging will differentiate. Definitive diagnosis often requires ultrasonography, cytology, and histopathology.

The diagnostic algorithm for mucometra and hydrometra begins with a thorough history and physical examination, including abdominal palpation and vaginal inspection. If uterine enlargement is suspected, the next step is abdominal ultrasonography, which is the most sensitive imaging modality. Ultrasound can confirm the presence of fluid-filled uterine horns, assess the uterine wall thickness, and evaluate the ovaries for cysts or tumors. The fluid is typically anechoic or hypoechoic, and the uterine wall may be thin or thickened depending on the degree of CEH. If the animal is not pregnant, serum progesterone measurement can help determine the stage of the estrous cycle; elevated progesterone (>2 ng/mL) indicates luteal phase. Vaginal cytology can be performed to assess the stage of the cycle and rule out vaginitis. If a vaginal discharge is present, a sample can be collected for cytology and bacterial culture, although the fluid is typically sterile. In cases where outflow obstruction is suspected, vaginoscopy or contrast radiography (vaginourethrography) may be useful. Complete blood count and serum biochemistry are recommended to rule out systemic inflammation or metabolic abnormalities, especially if pyometra is a concern. If the animal is a breeding animal and the condition is mild, a uterine biopsy may be considered, but this is rarely performed due to the risk of perforation. Ultimately, the definitive diagnosis is made by histopathological examination of the uterus after ovariohysterectomy. The algorithm should also include ruling out pregnancy, as this is the most common cause of uterine fluid in intact females.

Laboratory findings in mucometra and hydrometra are typically unremarkable unless secondary infection occurs. Complete blood count (CBC) is usually within normal limits, but may show mild leukocytosis if there is concurrent inflammation. Serum biochemistry is generally normal, but may reveal mild elevations in liver enzymes or globulins if there is chronic inflammation. Serum progesterone levels are typically elevated (>2 ng/mL) during diestrus, confirming luteal phase. Estrogen levels are low. Vaginal cytology may show a mixture of parabasal, intermediate, and superficial cells, depending on the stage of the cycle. In diestrus, the cytology is characterized by a sudden shift from superficial cells to parabasal and intermediate cells, with the presence of neutrophils and bacteria. However, in mucometra/hydrometra, the cytology may be normal for the stage. If vaginal discharge is present, cytology may reveal mucus and few cells, with no evidence of septic inflammation. Bacterial culture of the uterine fluid, if obtained, is usually negative or yields a light growth of normal flora. Urinalysis is typically normal. In cases of secondary pyometra, the CBC may show a marked leukocytosis with a left shift, and serum biochemistry may reveal azotemia, hyperglobulinemia, and elevated liver enzymes. Overall, laboratory findings are nonspecific and primarily used to rule out other conditions.

Imaging plays a crucial role in the diagnosis of mucometra and hydrometra. Abdominal ultrasonography is the modality of choice. Findings include the presence of anechoic or hypoechoic fluid within the uterine lumen, which may be seen as tubular structures with thin walls. The uterine wall may be normal or thickened, depending on the degree of CEH. In cases of CEH, multiple small anechoic cysts may be visible within the uterine wall. The ovaries should be evaluated for the presence of cysts or tumors. In dogs, the normal uterine diameter is <1 cm, but in mucometra/hydrometra, it can be significantly enlarged. The fluid may be homogeneous or contain some echogenic debris. Color Doppler may show reduced blood flow to the uterus. Radiography is less sensitive but may show a soft tissue opacity in the caudal abdomen, displacing the intestines. In pregnant animals, fetal mineralization can be seen after day 42-45, but this is not applicable here. Computed tomography (CT) and magnetic resonance imaging (MRI) are rarely needed but can provide detailed anatomical information, especially in cases of congenital anomalies. Vaginoscopy can be used to assess the cervix and vagina for obstructions. In cases of outflow obstruction, contrast radiography (vaginourethrography) can delineate the anatomy. Overall, ultrasonography is the most valuable imaging tool, and it should be performed systematically to rule out pregnancy and other uterine pathologies.

Cytological evaluation of vaginal smears is useful for staging the estrous cycle but is not diagnostic for mucometra/hydrometra. In diestrus, the smear shows a predominance of parabasal and intermediate cells, with few superficial cells, and the presence of neutrophils and bacteria. If vaginal discharge is present, a smear may reveal mucus and acellular debris. Fine-needle aspiration of the uterine fluid is not routinely performed due to the risk of uterine rupture, but if done, it would yield a sterile, mucinous or serous fluid with few cells. Histopathology of the uterus after ovariohysterectomy is the gold standard for diagnosis. Grossly, the uterus is distended with fluid, and the endometrium may show cystic changes. Microscopically, the endometrium exhibits cystic endometrial hyperplasia, with dilated glands lined by cuboidal to columnar epithelium, often containing eosinophilic secretion. The stroma may be edematous or fibrotic. In mucometra, the glandular lumina are filled with mucin, which stains positively with mucicarmine or PAS. In hydrometra, the fluid is more serous, and the endometrial changes may be less pronounced. There is typically no significant inflammatory infiltrate, unless secondary infection has occurred. Special stains, such as Gram stain, can be used to identify bacteria if present. The histopathological findings are essential to differentiate mucometra/hydrometra from pyometra and to assess the severity of CEH, which has prognostic implications for future fertility.

Treatment of mucometra and hydrometra depends on the clinical status of the animal and the owner's breeding goals. In non-breeding animals, ovariohysterectomy (OHE) is the treatment of choice and is curative. This eliminates the source of progesterone and prevents recurrence. In breeding animals, medical management may be attempted, especially in mild cases. Medical therapy aims to evacuate the uterine fluid and restore normal uterine function. Protocols include the use of prostaglandin F2α (PGF2α) to induce luteolysis and myometrial contraction, and antiprogestins such as aglepristone to block progesterone receptors. Cabergoline, a dopamine agonist, can also be used to reduce prolactin and progesterone secretion. A typical protocol for dogs involves aglepristone at 10 mg/kg SC on days 0, 1, and 2, followed by PGF2α (dinoprost) at 0.1-0.25 mg/kg SC q8h for 2-3 days, or cloprostenol at 1-2 μg/kg SC q48h. In cats, lower doses are used. Oxytocin can be used to enhance uterine contractions, but it is less effective in the presence of progesterone. Supportive care includes fluid therapy and antibiotics if secondary infection is suspected. However, medical management carries a risk of uterine rupture and is not always successful. After medical treatment, the animal should be bred on the next estrus, but fertility may be reduced. In cases of outflow obstruction, surgical correction may be necessary. Overall, OHE remains the most reliable treatment, and medical management should only be considered in valuable breeding animals with mild disease and close monitoring.

The prognosis for mucometra and hydrometra is generally good with appropriate treatment. In non-breeding animals, ovariohysterectomy is curative, and the prognosis is excellent. In breeding animals treated medically, the prognosis for resolution of clinical signs is good, but the prognosis for future fertility is guarded. The success of medical treatment depends on the severity of CEH and the duration of the condition. In one study, medical treatment with aglepristone and PGF2α resulted in successful resolution in about 70% of cases, but recurrence was common if the underlying hormonal imbalance was not corrected. The presence of secondary pyometra significantly worsens the prognosis, with a higher risk of systemic illness and mortality. Negative prognostic indicators include severe uterine distension, uterine wall thinning, and the presence of systemic signs. After medical treatment, the animal should be bred on the next estrus, but conception rates may be lower, and the risk of abortion is increased. In animals with congenital anomalies, the prognosis depends on the extent of the anomaly and the possibility of surgical correction. Overall, early diagnosis and treatment are key to a favorable outcome.

Follow-up after treatment depends on the chosen therapy. After ovariohysterectomy, routine postoperative care is required, including monitoring for surgical complications such as infection or dehiscence. The animal should be re-examined at 10-14 days for suture removal. No further reproductive monitoring is needed. After medical treatment, close monitoring is essential. Serial ultrasonography should be performed every 2-3 days during treatment to assess uterine size and fluid content. Serum progesterone levels should be monitored to ensure luteolysis. After treatment, the animal should be re-evaluated at the next estrus to confirm normal cycling. If breeding is planned, progesterone testing and vaginal cytology should be used to time ovulation. If the animal does not conceive within 1-2 cycles, further evaluation is warranted. In animals with a history of mucometra/hydrometra, the risk of recurrence is high, especially if they are not bred. Therefore, it is recommended to breed the animal on the next estrus or consider elective OHE if breeding is not desired. Long-term follow-up should include regular reproductive health checks, including ultrasonography, to monitor for recurrence or development of pyometra.

Clinical pearls: 1) Mucometra and hydrometra are often incidental findings; always perform ultrasonography in intact females with abdominal distension or vaginal discharge. 2) Serum progesterone >2 ng/mL confirms luteal phase, which is the typical context for these conditions. 3) In breeding animals, medical management with aglepristone and PGF2α can be successful, but must be initiated early and monitored closely. 4) Always rule out pregnancy before treating with prostaglandins or antiprogestins, as they can cause abortion. 5) Ovariohysterectomy is the definitive treatment and should be recommended for non-breeding animals. Pitfalls: 1) Mistaking mucometra/hydrometra for pyometra and treating with antibiotics alone, which is ineffective. 2) Administering oxytocin in the presence of high progesterone, which is ineffective and may cause uterine rupture. 3) Failing to detect outflow obstruction, leading to recurrence after medical treatment. 4) Overlooking ovarian cysts, which may require ovariohysterectomy to resolve. 5) Attempting medical management in severely affected animals, which may lead to uterine rupture and peritonitis. 6) Not monitoring progesterone levels during medical treatment, leading to incomplete luteolysis. 7) Breeding the animal too soon after medical treatment, before the uterus has fully involuted, increasing the risk of infertility.

Current drug protocols for mucometra and hydrometra are based on those used for pyometra, but with adjustments for the non-infected nature. The primary agents are: 1) Aglepristone (Alizin): 10 mg/kg SC on days 0, 1, and 2. It is a progesterone receptor antagonist that blocks the effects of progesterone, leading to cervical relaxation and uterine evacuation. 2) Prostaglandin F2α (Dinoprost tromethamine): 0.1-0.25 mg/kg SC q8h for 2-3 days, or 0.25 mg/kg SC q12h for 3 days. It induces luteolysis and myometrial contraction. 3) Cloprostenol: 1-2 μg/kg SC q48h for 2-3 treatments. It is a synthetic PGF2α analogue with fewer side effects. 4) Cabergoline: 5 μg/kg PO q24h for 5-7 days. It reduces prolactin and progesterone secretion. 5) Oxytocin: 0.5-2 IU/kg IM or SC, but only after progesterone levels have dropped below 2 ng/mL, as it is ineffective in the presence of high progesterone. 6) Antibiotics: If secondary infection is suspected, broad-spectrum antibiotics such as amoxicillin-clavulanate (12.5-25 mg/kg PO q12h) or enrofloxacin (5-10 mg/kg PO q24h) should be administered. 7) Supportive care: Intravenous fluids (e.g., lactated Ringer's solution at 60-100 mL/kg/day) and antiemetics if needed. In cats, doses are similar but adjusted for weight. It is crucial to monitor for side effects of PGF2α, including vomiting, salivation, and restlessness, which can be mitigated by pre-treatment with antiemetics. The use of these protocols should be guided by serial ultrasonography and progesterone measurements.

Evidence-based literature on mucometra and hydrometra is limited, but extrapolations from pyometra studies provide guidance. A landmark study by Fieni et al. (2001) demonstrated that aglepristone combined with cloprostenol was effective in treating pyometra in dogs, with a success rate of 85% for breeding animals. Similar protocols have been applied to mucometra/hydrometra, though with less evidence. A study by Verstegen et al. (2008) reported that medical treatment of CEH with aglepristone and PGF2α resulted in resolution of clinical signs in 70% of cases, but recurrence was common. The BSAVA Manual of Small Animal Reproduction (England & von Heimendahl, 2010) recommends OHE as the treatment of choice for non-breeding animals, and medical management only for valuable breeding animals with mild disease. The ACT (American College of Theriogenologists) guidelines emphasize the importance of early diagnosis and the use of ultrasonography to differentiate mucometra/hydrometra from pyometra. A retrospective study by Hagman et al. (2014) found that the prognosis for fertility after medical treatment of pyometra was guarded, with conception rates of 50-70%, and similar outcomes are expected for mucometra/hydrometra. Overall, the evidence supports the use of antiprogestins and prostaglandins for medical management, but OHE remains the most reliable treatment. Future research should focus on the long-term fertility outcomes and the role of CEH in the pathogenesis.